Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-C5 monoclonal antibody, has been clinically applied against neuroimmune diseases such as myasthenia...
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Frontiers Media S.A.
2023-03-01
|
| Serija: | Frontiers in Immunology |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1090548/full |